Skip to main content
All lobbying firms

THE CONAFAY GROUP, LLC

Registrant on federal lobbying filings · filed 2025 to 2026

$2,060,000 Income reported
19 Clients represented
91 Filings counted
0 Former members lobbying

Income is the fees this registrant reported being paid to lobby. 3 filings on this record were restated by a later amendment and are left out of every total here. Everything on this page is grouped by the registrant's LDA id (401004840), not by name.

 Lobbyists named 3
  • DARIN L GARDNER 49 filings · through 2026 Legislative Correspondent to Senator Tim Hutchinson; Research Assistant for Senate HELP Committee; Chief of Staff for Congresswoman Kay Granger
  • JOSH NARROW 44 filings · through 2026 Intern to Sen. Casey
  • BRYAN SHUY 43 filings · through 2026 Chief of Staff Rep. Harris; Asst. to Rep. Harris, HouseCmteon Approps; Dep. Asst. Sec and Chief of StaffHHS/Asst.Secretary for Preparedness and Response (ASPR)

A lobbyist who previously held a covered government position must disclose it. We flag the ones whose name resolves to a member of Congress and link the ones still in our roster. The revolving door collects them across every firm.

 Reported by year 2 years
  • 2026 $1,100,000 43 filings
  • 2025 $960,000 48 filings
 Issues lobbied 8

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

 Agencies and chambers lobbied 9
  • HOUSE OF REPRESENTATIVES 75
  • SENATE 75
  • Health & Human Services, Dept of (HHS) 11
  • Centers For Medicare and Medicaid Services (CMS) 5
  • Executive Office of the President (EOP) 5
  • Food & Drug Administration (FDA) 5
  • Commerce, Dept of (DOC) 3
  • Office of Management & Budget (OMB) 3
  • Veterans Affairs, Dept of (VA) 1
 Recent filings 94 total
Q3 report
REALTA LIFE SCIENCES, INC.
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $40,000 income · posted Oct 20, 2026
View →
Q3 report
REVAGENIX, INC.
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $50,000 income · posted Oct 20, 2026
View →
Q3 report
BRIGHT PATH LABORATORIES, INC.
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $40,000 income · posted Oct 20, 2026
View →
Q3 report
CHILD GENETIC SCREENING ALLIANCE
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $40,000 income · posted Oct 20, 2026
View →
Q3 report
KIRIN BIOMATERIALS
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $30,000 income · posted Oct 20, 2026
View →
Q3 termination
PKX BIO
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $10,000 income · posted Oct 20, 2026
View →
Q3 report
CRESILON, INC.
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $10,000 income · posted Oct 20, 2026
View →
Q3 termination
AGILITI HEALTH INC.
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $20,000 income · posted Oct 20, 2026
View →
Q3 report
DEFINIUM THERAPEUTICS (FKA MIND MEDICINE (MINDMED) INC.)
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $80,000 income · posted Oct 20, 2026
View →
Q3 report
ELUSYS THERAPEUTICS, INC
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $20,000 income · posted Oct 20, 2026
View →
Q3 report
ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · posted Oct 20, 2026
View →
Q3 report
MICROBIOME THERAPEUTICS INNOVATION GROUP (MTIG)
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $50,000 income · posted Oct 20, 2026
View →
Q3 report
MICROBIOME THERAPEUTICS INNOVATION GROUP (MTIG) Amended
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $50,000 income · posted Oct 20, 2026
View →
Q3 reportNo activity
CONAFAY GROUP ON BEHALF OF ANTIBIOTICS WORKING GROUP
3rd Quarter 2026 (July 1 - Sep 30) · posted Oct 20, 2026
View →
Q2 report
KIRIN BIOMATERIALS
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $30,000 income · posted Jul 20, 2026
View →
Q2 report
PKX BIO
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $10,000 income · posted Jul 20, 2026
View →
Q2 report
CRESILON, INC.
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $10,000 income · posted Jul 20, 2026
View →
Q2 report
CHILD GENETIC SCREENING ALLIANCE
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $40,000 income · posted Jul 20, 2026
View →
Q2 report
AGILITI HEALTH INC.
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $50,000 income · posted Jul 20, 2026
View →
Q2 report
BRIGHT PATH LABORATORIES, INC.
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $60,000 income · posted Jul 20, 2026
View →

Showing the 20 most recent of 94 filings. Search the explorer for "THE CONAFAY GROUP, LLC".

Filings through , the newest posted date on this record. Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.

Report a problem